Grundinformationen
- Standard-SMILES
C[C@]12CC[C@H](O)CC1=CC(=O)[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12- InChIKey
KPRGOTLNGIBVFL-GINZOMEDSA-N- Summenformel
- C19H26O3
- Durchschnittliche Molmasse
- 302,4 g/mol
- Monoisotopische Masse
- 302,18819469
Überblick
7-ketodehydroepiandrosterone is a 3beta-hydroxy-5-steroid that is dehydroepiandrosterone carrying an additional oxo group at position 7. It has a role as a nutraceutical, a prohormone and a human blood serum metabolite. It is a 3beta-hydroxy-Delta(5)-steroid, a 17-oxo steroid, a 7-oxo steroid and an androstanoid. It is functionally related to a dehydroepiandrosterone.
Namen und Bezeichner
- Bevorzugter Name
- 7-Keto-dehydroepiandrosterone
- IUPAC
- (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-7,17-dione
- Englischer Name
- 7-Keto-dehydroepiandrosterone
- Summenformel
- C19H26O3
- Molmasse
- 302.41
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
566-19-8- PubChem CID
- 193313
- DTXSID
DTXSID801024029- ChEMBL
CHEMBL1875999- ChEBI
CHEBI:183808- UNII
- 2334LJD2E9
- EC Number
- 111-754-6
- Nikkaji
- J672.472H
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2
- Polarare Oberfläche (TPSA)
- 54,4 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 3
- Frei drehbare Bindungen
- 0
- Schwere Atome
- 22
- Formalladung
- 0
- Komplexität
- 577
Physikochemische Eigenschaften
- Schmelzpunkt
- 245 · 245-248 °C
- Siedepunkt
- 477.1 · 477.1±45.0 °C(Predicted)
- Dichte
- 1.19 · 1.19±0.1 g/cm3(Predicted)
- Löslichkeit
- 25 mg/ml; · DMF: 25 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 15 mg/ml; Ethanol: 10 mg/ml
- Aggregatzustand
- A crystalline solid
- pka
- 14.67 · 14.67±0.60(Predicted)
- InChI
- InChI=1/C19H26O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h10,12-14,17,20H,3-9H2,1-2H3/t12-,13-,14-,17-,18-,19-/s3
- InChIKey
- KPRGOTLNGIBVFL-YQJRJXGQNA-N
- SMILES
- C[C@]12CC[C@H](O)CC1=CC(=O)[C@@]1([H])[C@]3([H])CCC(=O)[C@@]3(C)CC[C@]21[H] |&1:1,4,11,13,19,23,r|
- CAS Datenbank
- 566 · 566-19-8(CAS DataBase Reference)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H351 (100%): Suspected of causing cancer [Warning Carcinogenicity]
P203, P280, P318, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Gefahrenhinweise
Chemie und Industrie
Anwendungen
Beschreibung7-Ketodehydroepiandrosterone (7-Keto-dehydroepiandrosterone; 7-keto-DHEA), chemically known under 3-acetyl-7-oxo-dehydroepiandrosterone, is a naturally occurring metabolite of the steroid hormone dehydroepiandrosterone (DHEA) and is marketed as such an anti-obesity dietary supplement. The synthesis of 7-keto-DHEA begins with an irreversible hydroxylation of DHEA in the position C7 by cytochrome P450 7B1 (CYP7B1) under the formation of 7 α-hydroxy-dehydroepiandrosterone (7 α-OH-DHEA). β-hydroxysteroid dehydrogenase type 1 (11 β-HSD 1) then catalyzes the interconversion of 7 α-OH-DHEA and 7 β-hydroxy-dehydroepiandrosterone (7 β-OH-DHEA) through a 7-keto-DHEA intermediary. DHEA is a "parent hormone" produced by glands near the kidneys. However, unlike DHEA, 7-keto-DHEA is not converted to steroid hormones such as androgen and estrogen. Taking 7-keto-DHEA by mouth or applying it to the skin does not increase the level of steroid hormones in the blood. People take 7-keto-DHEA for obesity, muscle strength, anxiety, depression, and other conditions. However, there is no good scientific evidence to support these uses[1].
Anbieter50 Anbieter
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…